BREXIT

The European biomedical industry urges the United Kingdom and the EU to protect patients’ access to medicines before Brexit

The associations that represent the European and British biomedical industry insist on the importance of ensuring cooperation between the United Kingdom and the European Union in terms of pharmaceutical regulation
 

EFPIA report on BREXIT consequences: Assessing the impact on the life sciences industry of a change in the UK relationship with the EU

 
Download document

© 2020 FarmaIndustria All rights reserved